Patents by Inventor Joseph Noel
Joseph Noel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240118392Abstract: A two-dimensional (2D) lidar scanner includes a scan mirror assembly and rotary component. The scan mirror assembly includes a scan mirror and a mirror-tilting apparatus coupled to the scan mirror. The rotary component is coupled to the scan mirror assembly and can drive a rotary motion of the scan mirror assembly about a first axis. The mirror-tilting apparatus is configured to tilt the scan mirror about a second axis substantially perpendicular to the first axis in response to the rotary component driving the rotary motion of the scan mirror assembly. An orientation of the scan mirror is operable to control a first angle of reflection of a laser beam in a first dimension and a second angle of reflection of the laser beam in a second dimension during a lidar scanning process.Type: ApplicationFiled: September 28, 2023Publication date: April 11, 2024Applicant: VELODYNE LIDAR USA, INC.Inventors: Mathew Noel Rekow, Joseph B. Culkin
-
Publication number: 20240099944Abstract: A skin care emulsion composition that includes a continuous phase and a dispersed phase containing one or more retinoids. The continuous phase has a preservative system that includes one or more cell wall disrupters. The preservative system can be free of DMDM hydantoin, imadazolidinyl urea, diazlidinyl urea, sodium hydroxyl, methyl glycinate. The continuous phase can also include one or more antioxidants and one or more reducing agents. The composition can be chemically and physically stable.Type: ApplicationFiled: September 5, 2023Publication date: March 28, 2024Inventors: Claire Noel Wallace, Joseph Harry Jansen, Kai Lin Florence Ng
-
Publication number: 20230248653Abstract: A composition comprising a plurality of discrete particles comprising one or more cannabinoids disposed at least partially within a polymeric carrier having a maximum overall dimension of less than 1 micron. A composition comprising a plurality of discrete nanofibers comprising one or more cannabinoids disposed at least partially within a polymeric carrier is also disclosed along with methods to produce the same.Type: ApplicationFiled: April 13, 2023Publication date: August 10, 2023Inventor: Joseph Noel
-
Publication number: 20230029027Abstract: The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant prenyltransferase enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to the wild type prenyltransferase. The disclosure also provides methods of preparing such recombinant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.Type: ApplicationFiled: April 13, 2020Publication date: January 26, 2023Inventors: Michael MENDEZ, Joseph NOEL, Michael BURKART, Jeremy LANOISELEE, Kyle BOTSCH, Matthew SAUNDERS
-
Publication number: 20220098603Abstract: Transgenic plants and methods for terpenoid production leveraging such transgenic plants are provided. Such transgenic plants may comprise a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate in the plant. Such de novo IP production may be achieved through the overexpression of phosphomevalonate decarboxylase in conjunction with 3-hydroxy-3-methylglutarylCoA reductase, which can result in up to a 130-fold increase of terpenoid production as compared to a wild-type plant.Type: ApplicationFiled: December 14, 2021Publication date: March 31, 2022Inventors: Natalia Doudareva, Joseph Noel, Laura Henry, Suzanne T. Thomas
-
Patent number: 11198884Abstract: Transgenic plants and methods for terpenoid production leveraging such transgenic plants are provided. Such transgenic plants may comprise a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate in the plant. Such de novo IP production may be achieved through the overexpression of phosphomevalonate decarboxylase in conjunction with 3-hydroxy-3-methylglutarylCoA reductase, which can result in up to a 130-fold increase of terpenoid production as compared to a wild-type plant.Type: GrantFiled: May 26, 2019Date of Patent: December 14, 2021Assignee: Purdue Research FoundationInventors: Natalia Doudareva, Joseph Noel, Laura Henry, Suzanne T. Thomas
-
Publication number: 20210301267Abstract: The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant mutant ORF2 enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to WT ORF2. The disclosure also provides methods of preparing such ORF2 mutant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.Type: ApplicationFiled: October 27, 2020Publication date: September 30, 2021Inventors: Michael MENDEZ, Joseph NOEL, Michael BURKART, Jeremy LANOISELEE, Kyle BOTSCH, Matthew SAUNDERS
-
Publication number: 20210219573Abstract: A composition comprising one or more cannabosides, cannabinoid metabolites, or a combination thereof produced by an animal which has been fed a feedstock comprising one or more cannabinoids. A method to produce the compositions and articles comprising the composition are also disclosed.Type: ApplicationFiled: January 18, 2021Publication date: July 22, 2021Inventor: Joseph Noel
-
Publication number: 20210205224Abstract: A composition comprising a plurality of discrete particles comprising one or more cannabinoids disposed at least partially within a polymeric carrier having a maximum overall dimension of less than 1 micron. A composition comprising a plurality of discrete nanofibers comprising one or more cannabinoids disposed at least partially within a polymeric carrier is also disclosed along with methods to produce the same.Type: ApplicationFiled: November 4, 2020Publication date: July 8, 2021Inventor: Joseph Noel
-
Publication number: 20210192488Abstract: Systems and methods disclosed herein relate to reducing the losses associated with processing payments using credit card payment processing gateways. Payment processing gateways have different deposit success rates due to the gateways' varying arrangements with acquiring banks and the ability to process certain types of payments. A payment request related to a user may be received, wherein the request specifies a particular type of credit card, a transaction currency, and an amount. A payment application then routes, via a payment agent, the payment request to an adaptive gateway switching system (AGSS) in an attempt to complete a payment transaction. If in learning mode, the AGSS may randomly choose a payment processing gateway. Or the AGSS may choose the gateway based upon a learned gateway status based upon results learned through reinforcement learning. Upon receiving the result of a transaction attempt from the gateway, the agent reports the result to the AGSS.Type: ApplicationFiled: March 9, 2021Publication date: June 24, 2021Inventors: Amir MASSOUDI, Jun YAO, Joseph NOEL, Conrad Marco Egamino OLEGA, Darren Nicholas John WILLIAMS, Muhammad Umer FAROOQ
-
Publication number: 20210177914Abstract: A method of treating a medical condition addressed by one or more cannabinoids, comprising providing the cannabinoid enriched solid composition to a recipient in an amount sufficient to treat the medical condition. A composition and a method to produce the composition are also disclosed.Type: ApplicationFiled: December 11, 2020Publication date: June 17, 2021Inventor: Joseph Noel
-
Patent number: 10977639Abstract: Systems and methods disclosed herein relate to reducing the losses associated with processing payments using credit card payment processing gateways. Payment processing gateways have different deposit success rates due to the gateways' varying arrangements with acquiring banks and the ability to process certain types of payments. A payment request related to a user may be received, wherein the request specifies a particular type of credit card, a transaction currency, and an amount. A payment application then routes, via a payment agent, the payment request to an adaptive gateway switching system (AGSS) in an attempt to complete a payment transaction. If in learning mode, the AGSS may randomly choose a payment processing gateway. Or the AGSS may choose the gateway based upon a learned gateway status based upon results learned through reinforcement learning. Upon receiving the result of a transaction attempt from the gateway, the agent reports the result to the AGSS.Type: GrantFiled: June 3, 2016Date of Patent: April 13, 2021Assignee: FREELANCER TECHNOLOGY PTY LIMITEDInventors: Amir Massoudi, Jun Yao, Joseph Noel, Conrad Marco Egamino Olega, Darren Nicholas John Williams, Muhammad Umer Farooq
-
Patent number: 10894952Abstract: The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant mutant ORF2 enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to WT ORF2. The disclosure also provides methods of preparing such ORF2 mutant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.Type: GrantFiled: November 13, 2019Date of Patent: January 19, 2021Assignee: RENEW BIOPHARMA, INC.Inventors: Michael Mendez, Joseph Noel, Michael Burkart, Jeremy Lanoiselee, Kyle Botsch, Matthew Saunders
-
Publication number: 20200370060Abstract: Transgenic plants and methods for terpenoid production leveraging such transgenic plants are provided. Such transgenic plants may comprise a first heterologous nucleic acid encoding a polypeptide having 3-hydroxy-3-methylglutarylCoA reductase activity and a second heterologous nucleic acid encoding a polypeptide that introduces de novo formation of isopentenyl phosphate in the plant. Such de novo IP production may be achieved through the overexpression of phosphomevalonate decarboxylase in conjunction with 3-hydroxy-3-methylglutarylCoA reductase, which can result in up to a 130-fold increase of terpenoid production as compared to a wild-type plant.Type: ApplicationFiled: May 26, 2019Publication date: November 26, 2020Inventors: Natalia Doudareva, Joseph Noel, Laura Henry, Suzanne T. Thomas
-
Patent number: 10745674Abstract: The present invention relates to methods for producing polyketide synthase variants, and for altering the activity and/or substrate specificity of putative native and variant polyketide synthases. The present invention further relates to compositions comprising said polyketide synthase variants, compounds prepared using said polyketide synthase variants, and uses of said polyketide synthase variants. In one embodiment, said polyketide synthase variant is 2-pyrone synthase.Type: GrantFiled: March 5, 2015Date of Patent: August 18, 2020Assignees: SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Joseph Noel, Kate Woods, Marianne Bowman, Gordon Louie, Nancy Anderson Da Silva, Javier Pascual Cardenas
-
Publication number: 20200123511Abstract: The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant mutant ORF2 enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to WT ORF2. The disclosure also provides methods of preparing such ORF2 mutant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.Type: ApplicationFiled: November 13, 2019Publication date: April 23, 2020Inventors: Michael MENDEZ, Joseph NOEL, Michael BURKART, Jeremy LANOISELEE, Kyle BOTSCH, Matthew SAUNDERS
-
Publication number: 20170213204Abstract: Systems and methods disclosed herein relate to reducing the losses associated with processing payments using credit card payment processing gateways. Payment processing gateways have different deposit success rates due to the gateways' varying arrangements with acquiring banks and the ability to process certain types of payments. A payment request related to a user may be received, wherein the request specifies a particular type of credit card, a transaction currency, and an amount. A payment application then routes, via a payment agent, the payment request to an adaptive gateway switching system (AGSS) in an attempt to complete a payment transaction. If in learning mode, the AGSS may randomly choose a payment processing gateway. Or the AGSS may choose the gateway based upon a learned gateway status based upon results learned through reinforcement learning. Upon receiving the result of a transaction attempt from the gateway, the agent reports the result to the AGSS.Type: ApplicationFiled: June 3, 2016Publication date: July 27, 2017Inventors: Amir MASSOUDI, Jun YAO, Joseph NOEL, Conrad Marco Egamino OLEGA, Darren Nicholas John WILLIAMS, Muhammad Umer FAROOQ
-
Publication number: 20170073649Abstract: The present invention relates to methods for producing polyketide synthase variants, and for altering the activity and/or substrate specificity of putative native and variant polyketide synthases. The present invention further relates to compositions comprising said polyketide synthase variants, compounds prepared using said polyketide synthase variants, and uses of said polyketide synthase variants. In one embodiment, said polyketide synthase variant is 2-pyrone synthase.Type: ApplicationFiled: March 5, 2015Publication date: March 16, 2017Applicants: SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: JOSEPH NOEL, KATE WOODS, MARIANNE BOWMAN, GORDON LOUIE, NANCY ANDERSON DA SILVA, JAVIER PASCUAL CARDENAS
-
Publication number: 20150167014Abstract: The present invention relates to mutants of the plant aminotransferase VAS1 and to transgenic plants expressing said mutant protein that exhibit a modulated response to shade. In certain embodiments, the mutations of VAS1 uncouple VAS1 metabolic coordination of auxin and ethylene homeostasis, so that reduction of auxin is no longer linked (via VAS1) to reduction of ethylene. Such uncoupling allows for the generation of plants carrying a VAS1 mutant transgene that demonstrate a modulated response to shade, for example, less hypocotyl growth.Type: ApplicationFiled: December 4, 2014Publication date: June 18, 2015Applicant: THE SALK INSTITUTE FOR BIOLOGICAL STUDIESInventors: Joseph Noel, Joanne Chory, Yongxia Guo, Zuyu Zheng
-
Publication number: 20070298438Abstract: The present invention comprises crystalline polyketide synthases, isolated non-native polyketide synthases having the structural coordinates of said crystalline polyketide synthases, and nucleic acids encoding such non-native polyketide synthases. Also disclosed are methods of predicting the activity and/or substrated specificity of putative polyketide synthase, methods of identifying potential polyetide synthase substrates, and methods of identifying potential polyketide synthase inhibitors.Type: ApplicationFiled: May 14, 2007Publication date: December 27, 2007Inventors: Joseph Noel, Jean-Luc Ferrer, Joseph Jez, Mike Austin, Marianne Bowman